ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B
โ Scribed by M.J. ter Borg; B.E. Hansen; G. Bigot; B.L. Haagmans; H.L.A. Janssen
- Book ID
- 116631362
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 261 KB
- Volume
- 42
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In chronic hepatitis B, it is difficult to predict an early therapeutic response. We investigated the viral decline during therapy with pegylated interferon alpha-2b (PEG-IFN) with or without lamivudine in 266 HBeAg-positive chronic hepatitis B patients. In patients treated with PEG-IFN and lamivudi
The aims of this study were to evaluate the usefulness of quantitative hepatitis B e antigen (HBeAg) values for predicting HBeAg seroconversion in patients treated with peginterferon alfa-2a and to assess the dynamic changes in quantitative HBeAg during therapy, compared with conventional measures o